C. Andersson (London, United Kingdom), H. Kankaanranta (Seinäjoki, Finland)
Exercise moderates inflammation in asthma through increased redox buffering capacity
A. Freeman (Southampton, United Kingdom), D. Hill (Southampton, United Kingdom), D. Cellura (Southampton, United Kingdom), C. Spalluto (Southampton, United Kingdom), B. Fernandez (Southampton, United Kingdom), M. Minnion (Southampton, United Kingdom), H. Moyses (Southampton, United Kingdom), M. Feelisch (Southampton, United Kingdom), S. Jack (Southampton, United Kingdom), K. Staples (Southampton, United Kingdom), M. Grocott (Southampton, United Kingdom), T. Wilkinson (Southampton, United Kingdom)
|   |
Inhibition of VEGF and MMP-9 production by Pregabalin in human immunocompetent cells in vitro
F. Hajighasemi (Tehran, Islamic Republic of Iran), L. Darouni (Tehran, Islamic Republic of Iran)
| |
Viral induced epithelial antimicrobial defense in human asthma may depend on HDM exposure as well as HDM atopy
S. Cerps (Lund, Sweden), H. Akbarshahi (Lund, Sweden), S. Ramu (Lund, Sweden), M. Menzel (Lund, Sweden), C. Andersson (Lund, Sweden), M. Hvidtfeldt (Copenhagen, Denmark), A. Sverrild (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark), L. Uller (Lund, Sweden)
| |
Disturbance in bacterial community composition affects inflammatory ambiance and structural changes in non-Th2 asthma.
A. Konishcheva (Moscow, Russian Federation), V. Gervazieva (Moscow, Russian Federation), T. Ospelnikova (Moscow, Russian Federation)
| |
Different patterns of mast cell activation and smooth muscle contractions by MRGPRX2 agonist and antigen in guinea pig trachea
J. Liu (Stockholm, Sweden), J. Kolmert (Stockholm, Sweden), J. Säfholm (Stockholm, Sweden), C. Wheelock (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), G. Nilsson (Stockholm, Sweden), M. Adner (Stockholm, Sweden)
| |
IL13, IL31 and IL33 gene polymorphisms in moderate-to-severe asthma in Siberian children
S. Smirnova (Krasnoyarsk, Russian Federation), M. Smolnikova (Krasnoyarsk, Russian Federation), S. Tereshchenko (Krasnoyarsk, Russian Federation)
| |
Bone marrow derived dendritic cell (BMDC) adoptive transfer alleviate OVA-induced allergic airway inflammation in asthmatic mice
Z. Chen (Shanghai, China), K. Xu (Shanghai, China), N. Wu (Shanghai, China), Z. Min (Shanghai, China), Z. Jiang (Shanghai, China)
| |
Mepolizumab decreases urinary excretion of LTE4 in severe asthma
V. Yasinska (Stockholm, Sweden), J. Kolmert (Stockholm, Sweden), J. Zurita (Stockholm, Sweden), A. Quaranta (Stockholm, Sweden), A. Bossios (Stockholm, Sweden), N. Lazarinis (Stockholm, Sweden), B. Dahlén (Stockholm, Sweden), C. E. Wheelock (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), .. (on Behalf Of The Biocross Study Group) (Stockholm, Sweden)
| |
Inhibition of Mast Cell Degranulation by Surfactant Protein D
M. Leily (Southampton, United Kingdom), P. Trimby-Smith (Southampton, United Kingdom), R. Mackay (Southampton, United Kingdom), L. Lau (Southampton, United Kingdom), A. Walls (Southampton, United Kingdom)
| |
Neutrophil-to-lymphocyte ratio in patients with bronchiectasis and its correlation with low-grade inflammation; preliminary results from a single tertiary center.
P. Ghosh (Stockholm, Sweden), I. Gerhardson (Stockholm, Sweden), B. Dahlen (Stockholm, Sweden), A. Bossios (Stockholm, Sweden)
| |
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism.
R. Fassakhov (Kazan (Republic of Tatarstan), Russian Federation), S. Boichuk (Kazan (Republic of Tatarstan), Russian Federation)
| |
The influence of the allergen-specific immunotherapy (ASIT) against the backdrop of an immunomodulator in patients suffering from seasonal allergic rhinitis (SAR) on the level of cytokines, IgE and IgG.
I. Koretskaia (Dnepropetrovsk, Ukraine), Y. Dytyatkovska (Dnepropetrovsk, Ukraine)
| |
Roles of sensitization to Staphylococcal enterotoxin in patients with bronchiectasis
C. Morimoto (Kyoto, Japan), H. Matsumoto (Kyoto, Japan), T. Oguma (Kyoto, Japan), S. Sato (Kyoto, Japan), I. Ito (Kyoto, Japan), M. Kogo (Kyoto, Japan), N. Nomura (Kyoto, Japan), N. Tashima (Kyoto, Japan), H. Sunadome (Kyoto, Japan), T. Hirai (Kyoto, Japan)
| |
Development and characterisation of a multi-species COPD biofilm
B. Short (Paisley, United Kingdom), C. Williams (Paisley, United Kingdom), G. Litherland (Paisley, United Kingdom), F. Lundy (Belfast, United Kingdom), W. Mackay (Paisley, United Kingdom), G. Ramage (Glasgow, United Kingdom)
| |
Protein expression of TRP channels in the esophagus of patients with gastroesophageal reflux (GER)-associated cough
N. Takeda (Nagoya, Japan), T. Ueda (Nagoya, Japan), J. Go Yap (Nagoya, Japan), H. Nishiyama (Nagoya, Japan), R. Kurokawa (Nagoya, Japan), K. Fukumitsu (Nagoya, Japan), Y. Kanemitsu (Nagoya, Japan), E. Kubota (Nagoya, Japan), T. Kamiya (Nagoya, Japan), M. Takemura (Nagoya, Japan), A. Niimi (Nagoya, Japan)
| |
Completed autophagy protected airway epithelial barrier from antigens stimulation
Z. Zhou (Guangzhou, China), C. Yu (Guangzhou, China), S. Cai (Guangzhou, China)
| |
Photobiomodulation acting as an immunotherapeutic strategy for chronic obstructive diseases such as asthma and COPD
C. Alvarenga-Nascimento (São Paulo, Brazil), A. De Brito Léia (Vargem Grande Paulista, Brazil), T. Santos (São PauloGrande Paulista, Brazil), K. Herculano (São PauloGrande Paulista, Brazil), S. Soares (São PauloGrande Paulista, Brazil), R. Da Palma (Barcelona , Spain), A. Ligeiro-Oliveira (São Paulo, Brazil)
| |
Immunodeficiency associated bronchiectasis in the European Bronchiectasis Registry (EMBARC)
P. Mitchelmore (Exeter, United Kingdom), E. Polverino (Barcelona, Spain), J. Rademacher (Hannover, Germany), C. Haworth (Cambridge, United Kingdom), A. De Soyza (Newcastle, United Kingdom), M. Shteinburg (Haifa, Israel), A. Shoemark (Dundee, United Kingdom), J. Altenburg (Amsterdam, Netherlands), J. Chalmers (Dundee, United Kingdom), K. Dimakou (Athens, Greece), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), J. Elborn (Belfast, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), S. Aliberti (Milan, Italy), R. Menendez (Valencia, Spain), F. Blasi (Milan, Italy), P. Burgel (Paris, France), F. Ringshausen (Hannover, Germany), J. De Gracia (Barcelona, Spain), I. Meyts (Leuven, Belgium), M. Vendrell (Girona, Spain)
| |
Extrinsic and intrinsic airway obstruction is related to different airway smooth muscle phenotypes
M. Alvarez-Gonzalez (Mexico, Mexico), M. Alvarez-Santos (Mexico, Mexico), I. Pacheco-Alba (Mexico, Mexico), E. Eslava-De Jesus (Mexico, Mexico), A. Gonzalez-Lopez (Mexico, Mexico), R. Rojas-Madrid (Mexico, Mexico), Y. Perez-Del Valle (Mexico, Mexico), B. Bazan-Perkins (Mexico, Mexico)
| |